Cover Image
市場調查報告書

肝炎病毒迅速、POC (照護現場) 檢驗:醫療設備的開發平台評估

Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 550307
出版日期 內容資訊 英文 111 Pages
訂單完成後即時交付
價格
Back to Top
肝炎病毒迅速、POC (照護現場) 檢驗:醫療設備的開發平台評估 Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年09月01日 內容資訊: 英文 111 Pages
簡介

本報告提供全球肝炎病毒的迅速檢驗及POC (照護現場) 檢驗的市場上的主要開發中產品 (醫療設備) 的臨床實驗的進展調查,產品特性比較分析 (臨床實驗的各進展階段) ,再加上主要企業簡介及代表性產品,近來的市場動靜 (資本交易、產業聯盟等) 的資訊彙整,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 肝炎病毒迅速、POC檢驗概要

第3章 現在臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各領域
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期

第4章 在肝炎病毒迅速、POC檢驗:各企業現在臨床實驗中的開發中產品

  • 肝炎病毒迅速、POC檢驗的企業:各臨床實驗階段的開發中產品
  • 肝炎病毒迅速、POC檢驗:各臨床實驗階段的開發中產品

第5章 肝炎病毒迅速、POC檢驗的企業、產品概要

  • Akers Biosciences Inc
    • 開發中產品及進行中的臨床實驗概要
  • Alere Inc
  • Atomo Diagnostics Pty Limited
  • Biocartis SA
  • bioLytical Laboratories Inc
  • Biosurfit, SA
  • Biotech Consortium India Ltd
  • Cepheid
  • Chembio Diagnostic Systems Inc
  • ChipCare Corp
  • Co-Diagnostics HBDC, Inc.
  • Correlia Biosystems, Inc.
  • Daktari Diagnostics, Inc.
  • Diagnostics For All
  • Fast-track diagnostics S.a.r.l.
  • GeneBio Systems Inc
  • genedrive plc
  • Group K Diagnostics
  • ImmunoScience Inc
  • MedMira Inc.
  • Micronics Inc
  • Molbio Diagnostics Pvt. Ltd.
  • NOWDiagnostics
  • OPKO Health Inc
  • Sedia Biosciences Corp
  • University of California Irvine
  • Wave 80 Biosciences Inc
  • Xagenic Inc.

第6章 肝炎病毒迅速、POC檢驗市場:目前的趨勢

第7章 附錄

圖表一覽

目錄
Product Code: GDME0417EPD

GlobalData's Medical Devices sector report, "Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Medical Devices Pipeline Assessment, 2017" provides an overview of Hepatitis Viruses Rapid Tests & POC (Point Of Care) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hepatitis Viruses Rapid Tests & POC (Point Of Care) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope:

  • Extensive coverage of the Hepatitis Viruses Rapid Tests & POC (Point Of Care) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hepatitis Viruses Rapid Tests & POC (Point Of Care) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy:

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hepatitis Viruses Rapid Tests & POC (Point Of Care) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Hepatitis Viruses Rapid Tests & POC (Point Of Care) Overview

3. Products under Development

  • 3.1. Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Pipeline Products by Stage of Development
  • 3.2. Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Pipeline Products by Territory
  • 3.3. Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Pipeline Products by Regulatory Path
  • 3.4. Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Pipeline Products by Estimated Approval Date

4. Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Pipeline Products under Development by Companies

  • 4.1. Hepatitis Viruses Rapid Tests & POC (Point Of Care) Companies - Pipeline Products by Stage of Development
  • 4.2. Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Pipeline Products by Stage of Development

5. Hepatitis Viruses Rapid Tests & POC (Point Of Care) Companies and Product Overview

  • 5.1. Akers Biosciences Inc Company Overview
    • 5.1.1. Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Alere Inc Company Overview
    • 5.2.1. Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Atomo Diagnostics Pty Limited Company Overview
    • 5.3.1. Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Biocartis SA Company Overview
    • 5.4.1. Biocartis SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. bioLytical Laboratories Inc Company Overview
    • 5.5.1. bioLytical Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Biosurfit, SA Company Overview
    • 5.6.1. Biosurfit, SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Biotech Consortium India Ltd Company Overview
    • 5.7.1. Biotech Consortium India Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Cepheid Company Overview
    • 5.8.1. Cepheid Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Chembio Diagnostic Systems Inc Company Overview
    • 5.9.1. Chembio Diagnostic Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. ChipCare Corp Company Overview
    • 5.10.1. ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Co-Diagnostics HBDC, Inc. Company Overview
    • 5.11.1. Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Correlia Biosystems, Inc. Company Overview
    • 5.12.1. Correlia Biosystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. Daktari Diagnostics, Inc. Company Overview
    • 5.13.1. Daktari Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Diagnostics For All Company Overview
    • 5.14.1. Diagnostics For All Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. Fast-track diagnostics S.a.r.l. Company Overview
    • 5.15.1. Fast-track diagnostics S.a.r.l. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. GeneBio Systems Inc Company Overview
    • 5.16.1. GeneBio Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. genedrive plc Company Overview
    • 5.17.1. genedrive plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. Group K Diagnostics Company Overview
    • 5.18.1. Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. ImmunoScience Inc Company Overview
    • 5.19.1. ImmunoScience Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. MedMira Inc. Company Overview
    • 5.20.1. MedMira Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. Micronics Inc Company Overview
    • 5.21.1. Micronics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. Molbio Diagnostics Pvt. Ltd. Company Overview
    • 5.22.1. Molbio Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. NOWDiagnostics Company Overview
    • 5.23.1. NOWDiagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. OPKO Health Inc Company Overview
    • 5.24.1. OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. Sedia Biosciences Corp Company Overview
    • 5.25.1. Sedia Biosciences Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26. University of California Irvine Company Overview
    • 5.26.1. University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27. Wave 80 Biosciences Inc Company Overview
    • 5.27.1. Wave 80 Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28. Xagenic Inc. Company Overview
    • 5.28.1. Xagenic Inc. Pipeline Products & Ongoing Clinical Trials Overview

6. Hepatitis Viruses Rapid Tests & POC (Point Of Care)- Recent Developments

  • 6.1. Aug 08, 2017: Akers Biosciences Announces Board Changes
  • 6.2. Aug 07, 2017: Quotient Reports Results From Ongoing MosaiQ Performance Evaluation Studies and First Quarter Fiscal 2018 Financial Results
  • 6.3. Aug 03, 2017: Akers Biosciences Announces Second Quarter Trading Update
  • 6.4. Jul 28, 2017: Merck Announces Second-Quarter 2017 Financial Results
  • 6.5. Jul 17, 2017: Governor Abbott Announces Merck IT Hub In Austin
  • 6.6. May 22, 2017: Quotient Reports Continued Progress on the Commercial Scale-up of MosaiQ and Fourth Quarter and Fiscal Year 2017 Financial Results
  • 6.7. May 16, 2017: NOWDiagnostics CEO Kevin Clark to Address Technology Conference
  • 6.8. May 16, 2017: Akers Biosciences Announces Q1 2017 Earnings
  • 6.9. May 02, 2017: Merck Announces First-Quarter 2017 Financial Results
  • 6.10. Apr 24, 2017: Grifols Strengthens Position as Global Provider of Diagnostic Testing Solutions with Five-Year Extension of OraSure Technologies Agreement and a New Manufacturing Facility
  • 6.11. Apr 11, 2017: Genedrive Announces Hepatitis C Assay performance data accepted for presentation at the International Liver Confrence , April 19-23 in Amsterdam
  • 6.12. Apr 11, 2017: Akers Bioscience: Financial Results for the Year Ended December 31, 2016
  • 6.13. Apr 11, 2017: Akers Biosciences Reports Earnings for Fiscal Year 2016
  • 6.14. Apr 10, 2017: Dr. John H. Noseworthy Nominated to Stand for Election to Merck Board of Directors
  • 6.15. Apr 06, 2017: Merck Receives 2017 ENERGY STAR Sustained Excellence Award from U. S. Environmental Protection Agency
  • 6.16. Mar 31, 2017: City Of Austin Announces Merck Economic Development Proposal
  • 6.17. Mar 30, 2017: Akers Biosciences Reports Preliminary Unaudited Earnings Highlights for Fiscal Year 2016
  • 6.18. Mar 30, 2017: Genedrive: Interim Results for the six month period to 31 December 2016
  • 6.19. Mar 27, 2017: Genedrive HCV Assay Submitted For CE IVD Certification
  • 6.20. Mar 08, 2017: genedrive Announces Successful Clinical Results for Genedrive HCV Assay
  • 6.21. Feb 09, 2017: Quotient Announces Appointment of Christopher Lindop as Chief Financial Officer
  • 6.22. Feb 06, 2017: Quotient Reports Continued Progress on the Commercial Scale-up of MosaiQ and Third Quarter Fiscal 2017 Financial Results
  • 6.23. Feb 02, 2017: Merck Announces Fourth-Quarter and Full-Year 2016 Financial Results
  • 6.24. Jan 25, 2017: Daktari Achieves Milestone in Its Merck HCV Collaboration
  • 6.25. Nov 29, 2016: genedrive: Update on CFO Appointment
  • 6.26. Nov 14, 2016: Akers Biosciences Announces Q3 Earnings
  • 6.27. Nov 02, 2016: Quotient Announces CFO Transition
  • 6.28. Oct 31, 2016: Quotient Second Quarter Fiscal 2017 Financial Results
  • 6.29. Oct 31, 2016: Quotient Reports Continued Progress on the Commercial Scale-up of MosaiQ and Second Quarter Fiscal 2017 Financial Results
  • 6.30. Oct 25, 2016: Merck Announces Third-Quarter 2016 Financial Results
  • 6.31. Oct 11, 2016: Genedrive Announces Preliminary Results for the year ended 30 June 2016
  • 6.32. Sep 30, 2016: Correlia Bio Receives NIH SBIR Grant to Develop Diagnostic Test For Hepatitis C Infection
  • 6.33. Sep 21, 2016: Genedrive Announces Appointment of Chief Financial Officer

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Pipeline Products by Stage of Development
  • Table 2: Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Pipeline Products by Territory
  • Table 3: Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Pipeline Products by Regulatory Path
  • Table 4: Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Pipeline Products by Estimated Approval Date
  • Table 5: Hepatitis Viruses Rapid Tests & POC (Point Of Care) Companies - Pipeline Products by Stage of Development
  • Table 6: Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Pipeline Products by Stage of Development
  • Table 7: Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 8: PIFA Hep B / Hep C - Product Status
  • Table 9: PIFA Hep B / Hep C - Product Description
  • Table 10: PIFA PLUSS Hepatitis B Assay - Product Status
  • Table 11: PIFA PLUSS Hepatitis B Assay - Product Description
  • Table 12: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 13: Alere i System - HBV Assay - Product Status
  • Table 14: Alere i System - HBV Assay - Product Description
  • Table 15: Alere q Analyzer - HCV VL Assay - Product Status
  • Table 16: Alere q Analyzer - HCV VL Assay - Product Description
  • Table 17: Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 18: AtomoRapid - Hepatitis C - Product Status
  • Table 19: AtomoRapid - Hepatitis C - Product Description
  • Table 20: Biocartis SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: Idylla Viral Load Assay - HBV - Product Status
  • Table 22: Idylla Viral Load Assay - HBV - Product Description
  • Table 23: Idylla Viral Load Assay - HCV - Product Status
  • Table 24: Idylla Viral Load Assay - HCV - Product Description
  • Table 25: bioLytical Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 26: INSTI Test - Hepatitis B - Product Status
  • Table 27: INSTI Test - Hepatitis B - Product Description
  • Table 28: INSTI Test - Hepatitis C - Product Status
  • Table 29: INSTI Test - Hepatitis C - Product Description
  • Table 30: Biosurfit, SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 31: Spinit Device - Hepatitis C Biomarker Assay - Product Status
  • Table 32: Spinit Device - Hepatitis C Biomarker Assay - Product Description
  • Table 33: Biotech Consortium India Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 34: Diagnostic Kit - Hepatitis A - Product Status
  • Table 35: Diagnostic Kit - Hepatitis A - Product Description
  • Table 36: Cepheid Pipeline Products & Ongoing Clinical Trials Overview
  • Table 37: GeneXpert Omni - Xpert HCV Viral Load - Product Status
  • Table 38: GeneXpert Omni - Xpert HCV Viral Load - Product Description
  • Table 39: Chembio Diagnostic Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 40: DPP Hepatitis C Virus Assay - Product Status
  • Table 41: DPP Hepatitis C Virus Assay - Product Description
  • Table 42: Next Generation DPP HCV Assay - Product Status
  • Table 43: Next Generation DPP HCV Assay - Product Description
  • Table 44: ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 45: Diagnostic Assay - Hepatitis C - Product Status
  • Table 46: Diagnostic Assay - Hepatitis C - Product Description
  • Table 47: Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 48: Molecular Diagnostic Kit - Hepatitis B - Product Status
  • Table 49: Molecular Diagnostic Kit - Hepatitis B - Product Description
  • Table 50: Correlia Biosystems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 51: Diagnostic Test - Hepatitis C Infection - Product Status
  • Table 52: Diagnostic Test - Hepatitis C Infection - Product Description
  • Table 53: Daktari Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 54: Aspect - HCV-cAg Test - Product Status
  • Table 55: Aspect - HCV-cAg Test - Product Description
  • Table 56: Daktari HCV Assay - Product Status
  • Table 57: Daktari HCV Assay - Product Description
  • Table 58: Diagnostics For All Pipeline Products & Ongoing Clinical Trials Overview
  • Table 59: Paper-Based Microfluidic Device - Hepatitis B - Product Status
  • Table 60: Paper-Based Microfluidic Device - Hepatitis B - Product Description
  • Table 61: Paper-Based Microfluidic Device - Hepatitis C - Product Status
  • Table 62: Paper-Based Microfluidic Device - Hepatitis C - Product Description
  • Table 63: Fast-track diagnostics S.a.r.l. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 64: FTD HDV RNA Assay - Product Status
  • Table 65: FTD HDV RNA Assay - Product Description
  • Table 66: FTD Hepatitis B DNA Assay - Product Status
  • Table 67: FTD Hepatitis B DNA Assay - Product Description
  • Table 68: FTD Hepatitis C RNA Assay - Product Status
  • Table 69: FTD Hepatitis C RNA Assay - Product Description
  • Table 70: FTD Hepatitis E RNA Assay - Product Status
  • Table 71: FTD Hepatitis E RNA Assay - Product Description
  • Table 72: GeneBio Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 73: HCV Assay - Product Status
  • Table 74: HCV Assay - Product Description
  • Table 75: genedrive plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 76: Genedrive HCV ID Kit - Product Status
  • Table 77: Genedrive HCV ID Kit - Product Description
  • Table 78: Genedrive Next-Generation HCV Test - Product Status
  • Table 79: Genedrive Next-Generation HCV Test - Product Description
  • Table 80: Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • Table 81: Multidiagnostic - Hepatitis A-D Virus Test - Product Status
  • Table 82: Multidiagnostic - Hepatitis A-D Virus Test - Product Description
  • Table 83: Multidiagnostic - Hepatitis Load Test - Product Status
  • Table 84: Multidiagnostic - Hepatitis Load Test - Product Description
  • Table 85: ImmunoScience Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 86: Salivax - Hepatitis B - Product Status
  • Table 87: Salivax - Hepatitis B - Product Description
  • Table 88: Salivax - Hepatitis C - Product Status
  • Table 89: Salivax - Hepatitis C - Product Description
  • Table 90: MedMira Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 91: Reveal HBsAg Rapid Test - Product Status
  • Table 92: Reveal HBsAg Rapid Test - Product Description
  • Table 93: Micronics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 94: PanNAT - HBV Assay - Product Status
  • Table 95: PanNAT - HBV Assay - Product Description
  • Table 96: PanNAT - HCV Assay - Product Status
  • Table 97: PanNAT - HCV Assay - Product Description
  • Table 98: Molbio Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 99: Truenat HCV Viral Load Assay - Product Status
  • Table 100: Truenat HCV Viral Load Assay - Product Description
  • Table 101: Truenat HPV Assay - Product Status
  • Table 102: Truenat HPV Assay - Product Description
  • Table 103: NOWDiagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • Table 104: ADEXUSDx Hepatitis B Test - Product Status
  • Table 105: ADEXUSDx Hepatitis B Test - Product Description
  • Table 106: ADEXUSDx Hepatitis C Test - Product Status
  • Table 107: ADEXUSDx Hepatitis C Test - Product Description
  • Table 108: OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 109: Diagnostic Assay - HBV - Product Status
  • Table 110: Diagnostic Assay - HBV - Product Description
  • Table 111: Sedia Biosciences Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 112: Asante Rapid Hepatitis C (Anti-Hepatitis C Antibody) Blood/Oral Fluid Test - Product Status
  • Table 113: Asante Rapid Hepatitis C (Anti-Hepatitis C Antibody) Blood/Oral Fluid Test - Product Description
  • Table 114: Rapid Anti-Hepatitis B Ab Blood/Oral Fluid Test - Product Status
  • Table 115: Rapid Anti-Hepatitis B Ab Blood/Oral Fluid Test - Product Description
  • Table 116: University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview
  • Table 117: One-Step Screening And Diagnostic Test - HCV Infection - Product Status
  • Table 118: One-Step Screening And Diagnostic Test - HCV Infection - Product Description
  • Table 119: Wave 80 Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 120: EOSCAPE-CLEF - Product Status
  • Table 121: EOSCAPE-CLEF - Product Description
  • Table 122: EOSCAPE-HBV DNA - Product Status
  • Table 123: EOSCAPE-HBV DNA - Product Description
  • Table 124: EOSCAPE-HBV DNA PLUS - Product Status
  • Table 125: EOSCAPE-HBV DNA PLUS - Product Description
  • Table 126: EOSCAPE-HCV RNA - Product Status
  • Table 127: EOSCAPE-HCV RNA - Product Description
  • Table 128: Xagenic Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 129: Hepatitis C Virus Genotyping Assay - Product Status
  • Table 130: Hepatitis C Virus Genotyping Assay - Product Description
  • Table 131: Glossary

List of Figures

  • Figure 1: Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Pipeline Products by Stage of Development
  • Figure 2: Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Pipeline Products by Territory
  • Figure 3: Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Pipeline Products by Regulatory Path
  • Figure 4: Hepatitis Viruses Rapid Tests & POC (Point Of Care) - Pipeline Products by Estimated Approval Date
Back to Top